Zouboulis CC, Keitel W: A historical review of early descriptions of Adamantiades-Behcet's disease. J Invest Dermatol. 2002, 119 (1): 201-205. 10.1046/j.1523-1747.2002.01798.x.
Article
CAS
PubMed
Google Scholar
McGonagle D, McDermott MF: A proposed classification of the immunological diseases. PLoS Med. 2006, 3 (8): e297-10.1371/journal.pmed.0030297.
Article
PubMed Central
PubMed
Google Scholar
Criteria for diagnosis of Behcet's disease: International Study Group for Behcet's Disease. Lancet. 1990, 335 (8697): 1078-1080.
Google Scholar
Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M: Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol. 1982, 100 (9): 1455-1458. 10.1001/archopht.1982.01030040433013.
Article
CAS
PubMed
Google Scholar
Verity DH, Wallace GR, Vaughan RW, Kondeatis E, Madanat W, Zureikat H, Fayyad F, Marr JE, Kanawati CA, Stanford MR: HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behcet's disease. Tissue Antigens. 1999, 54 (3): 264-272. 10.1034/j.1399-0039.1999.540307.x.
Article
CAS
PubMed
Google Scholar
Gul A, Inanc M, Ocal L, Aral O, Konice M: Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis. 2000, 59 (8): 622-625. 10.1136/ard.59.8.622.
Article
PubMed Central
CAS
PubMed
Google Scholar
Saadoun D, Wechsler B, Desseaux K, Le Thi Huong D, Amoura Z, Resche-Rigon M, Cacoub P: Mortality in Behcet's disease. Arthritis Rheum. 2010, 62 (9): 2806-2812. 10.1002/art.27568.
Article
CAS
PubMed
Google Scholar
Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S: Renal Behcet's disease: a cumulative analysis. Semin Arthritis Rheum. 2002, 31 (5): 317-337. 10.1053/sarh.2002.31721.
Article
PubMed
Google Scholar
Saadoun D, Cassoux N, Wechsler B, Boutin D, Terrada C, Lehoang P, Bodaghi B, Cacoub P: Ocular manifestations of Behcet's disease. Rev Med Interne. 2010, 31 (8): 545-550. 10.1016/j.revmed.2009.04.014.
Article
CAS
PubMed
Google Scholar
Saadoun D, Wechsler B, Terrada C, Hajage D, Le Thi Huong D, Resche-Rigon M, Cassoux N, Le Hoang P, Amoura Z, Bodaghi B, Cacoub P: Azathioprine in severe uveitis of Behcet's disease. Arthritis Care Res (Hoboken). 2010, 62 (12): 1733-1738. 10.1002/acr.20308.
Article
CAS
Google Scholar
Calamia KT, Schirmer M, Melikoglu M: Major vessel involvement in Behcet's disease: an update. Curr Opin Rheumatol. 2011, 23 (1): 24-31. 10.1097/BOR.0b013e3283410088.
Article
PubMed
Google Scholar
Saadoun D, Asli B, Wechsler B, Houman H, Geri G, Desseaux K, Piette JC, Huong DL, Amoura Z, Salem TB, Cluzel P, Koskas F, Resche-Rigon M, Cacoub P: Long-Term Outcome of Arterial Lesions in Behcet Disease: A Series of 101 Patients. Medicine (Baltimore). 2012, 91 (1): 18-24. 10.1097/MD.0b013e3182428126.
Article
Google Scholar
Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T: Pathologic features of Behcet's syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985, 16 (8): 790-795. 10.1016/S0046-8177(85)80250-1.
Article
CAS
PubMed
Google Scholar
Hamuryudan V, Er T, Seyahi E, Akman C, Tuzun H, Fresko I, Yurdakul S, Numan F, Yazici H: Pulmonary artery aneurysms in Behcet syndrome. Am J Med. 2004, 117 (11): 867-870. 10.1016/j.amjmed.2004.05.027.
Article
PubMed
Google Scholar
Wechsler B, Du LT, Kieffer E: Cardiovascular manifestations of Behcet's disease. Ann Med Interne (Paris). 1999, 150 (7): 542-554.
CAS
Google Scholar
Geri G, Wechsler B, Thi Huong Du L, Isnard R, Piette JC, Amoura Z, Resche-Rigon M, Cacoub P, Saadoun D: Spectrum of cardiac lesions in behcet disease: a series of 52 patients and review of the literature. Medicine (Baltimore). 2012, 91 (1): 25-34. 10.1097/MD.0b013e3182428f49.
Article
Google Scholar
Wechsler B, Piette JC, Godeau P: Behcet disease and corticotherapy. Presse Med. 1999, 28 (33): 1819-
CAS
PubMed
Google Scholar
Akman-Demir G, Serdaroglu P, Tasci B: Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients, The Neuro-Behcet Study Group. Brain. 1999, 122 (Pt 11): 2171-2182.
Article
PubMed
Google Scholar
Wechsler B, Sbai A, Du-Boutin LT, Duhaut P, Dormont D, Piette JC: Neurological manifestations of Behcet's disease. Rev Neurol (Paris). 2002, 158 (10 Pt 1): 926-933.
CAS
Google Scholar
Saadoun D, Wechsler B, Resche-Rigon M, Trad S, Le Thi Huong D, Sbai A, Dormont D, Amoura Z, Cacoub P, Piette JC: Cerebral venous thrombosis in Behcet's disease. Arthritis Rheum. 2009, 61 (4): 518-526. 10.1002/art.24393.
Article
CAS
PubMed
Google Scholar
Yurdakul S, Tuzuner N, Yurdakul I, Hamuryudan V, Yazici H: Gastrointestinal involvement in Behcet's syndrome: a controlled study. Ann Rheum Dis. 1996, 55 (3): 208-210. 10.1136/ard.55.3.208.
Article
PubMed Central
CAS
PubMed
Google Scholar
de Chambrun MP, Wechsler B, Geri G, Cacoub P, Saadoun D: New insights into the pathogenesis of Behcet's disease. Autoimmun Rev. 2011 Dec 11, [Epub ahead of print]
Google Scholar
Lehner T: The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet's disease. Int Rev Immunol. 1997, 14 (1): 21-32. 10.3109/08830189709116842.
Article
CAS
PubMed
Google Scholar
Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, Cho YH, Bang D, O'Shea J, Wallace GR, Gadina M, Kastner DL, Gul A: Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet. 2010, 42 (8): 698-702. 10.1038/ng.625.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, Kitaichi N, Namba K, Horie Y, Takeno M, Sugita S, Mochizuki M, Bahram S, Ishigatsubo Y, Inoko H: Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet. 2010, 42 (8): 703-706. 10.1038/ng.624.
Article
CAS
PubMed
Google Scholar
Hirohata S: Histopathology of central nervous system lesions in Behcet's disease. J Neurol Sci. 2008, 267 (1–2): 41-47.
Article
CAS
PubMed
Google Scholar
Hasan A, Fortune F, Wilson A, Warr K, Shinnick T, Mizushima Y, van der Zee R, Stanford MR, Sanderson J, Lehner T: Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet. 1996, 347 (9004): 789-794. 10.1016/S0140-6736(96)90868-5.
Article
CAS
PubMed
Google Scholar
Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D, Tran TA, Bodaghi B, Musset L, Soumelis V, Klatzmann D, Cacoub P, Saadoun D: Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease. J Allergy Clin Immunol. 2011, 128 (3): 655-664. 10.1016/j.jaci.2011.05.029.
Article
CAS
PubMed
Google Scholar
Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kotter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stubiger N, Yurdakul S, Yazici H: EULAR recommendations for the management of Behcet disease. Ann Rheum Dis. 2008, 67 (12): 1656-1662. 10.1136/ard.2007.080432.
Article
CAS
PubMed
Google Scholar
Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H: The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003, 82 (1): 60-76. 10.1097/00005792-200301000-00006.
Article
Google Scholar
Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozyazgan Y, Silman A, Serdaroglu S, Oguz V, Yurdakul S, Lovatt GE, et al: A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med. 1990, 322 (5): 281-285. 10.1056/NEJM199002013220501.
Article
CAS
PubMed
Google Scholar
Arida A, Fragiadaki K, Giavri E, Sfikakis PP: Anti-TNF agents for Behcet's disease: analysis of published data on 369 patients. Semin Arthritis Rheum. 2011, 41 (1): 61-70. 10.1016/j.semarthrit.2010.09.002.
Article
CAS
PubMed
Google Scholar
Deuter CM, Zierhut M, Mohle A, Vonthein R, Stobiger N, Kotter I: Long-term remission after cessation of interferon-alpha treatment in patients with severe uveitis due to Behcet's disease. Arthritis Rheum. 2010, 62 (9): 2796-2805. 10.1002/art.27581.
Article
CAS
PubMed
Google Scholar
Davatchi F, Sadeghi Abdollahi B, Tehrani Banihashemi A, Shahram F, Nadji A, Shams H, Chams-Davatchi C: Colchicine versus placebo in Behcet's disease: randomized, double-blind, controlled crossover trial. Mod Rheumatol. 2009, 19 (5): 542-549. 10.1007/s10165-009-0200-2.
Article
CAS
PubMed
Google Scholar
Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H: Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998, 128 (6): 443-450.
Article
CAS
PubMed
Google Scholar
Yasui K, Ohta K, Kobayashi M, Aizawa T, Komiyama A: Successful treatment of Behcet disease with pentoxifylline. Ann Intern Med. 1996, 124 (10): 891-893.
Article
CAS
PubMed
Google Scholar
Sharquie KE, Najim RA, Abu-Raghif AR: Dapsone in Behcet's disease: a double-blind, placebo-controlled, cross-over study. J Dermatol. 2002, 29 (5): 267-279.
Article
CAS
PubMed
Google Scholar